The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas

Frontline of ASCT in High-risk DLBCL

NCT05831865 ·Status: RECRUITING

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

NCT00499018 ·Status: UNKNOWN ·Phase: PHASE3

Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)

NCT04237168 ·Status: UNKNOWN

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

NCT02339805 ·Status: COMPLETED ·Phase: NA

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

NCT02805218 ·Status: COMPLETED ·Phase: PHASE4

A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma

NCT04434833 ·Status: UNKNOWN

A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)

NCT05192486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

NCT03018626 ·Status: UNKNOWN ·Phase: PHASE3

Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma

NCT02474550 ·Status: UNKNOWN

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT06693973 ·Status: RECRUITING ·Phase: EARLY_PHASE1

This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas

NCT01279772 ·Status: TERMINATED

Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients

NCT03870412 ·Status: UNKNOWN ·Phase: NA

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

NCT04491721 ·Status: ENROLLING_BY_INVITATION

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT05524298 ·Status: RECRUITING

TREatment of degeNerative and Neoplastic Diseases With Rituximab

NCT01277172 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients

NCT03364439 ·Status: COMPLETED ·Phase: PHASE2

Prognostic Value Of Lymphocyte Count and Lymphocyte/ Monocyte Ratio in Patients With Hodgkin's Lymphoma

NCT04893538 ·Status: UNKNOWN

A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients

NCT01793844 ·Status: UNKNOWN

Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression

NCT03977623 ·Status: UNKNOWN

the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma

NCT05834751 ·Status: UNKNOWN ·Phase: NA

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

NCT01448096 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

NCT01340443 ·Status: COMPLETED

A Multicenter, Phase 2 Study Evaluating the Value of Radiotherapy in Advanced Diffuse Large B-cell Lymphoma Patients With Extranodal Involvement and Large Tumors Undergoing Immunochemotherapy for PET-CT Assessment of Complete Remission

NCT05874778 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL

NCT03958916 ·Status: UNKNOWN

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

NCT04300101 ·Status: RECRUITING